Daren Fearon
Diamond Light Source
Didcot, ENG, United Kingdom
Didcot, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
X-ray Crystallography-Guided Design and Synthesis of Cyclopentyl Heteroaryl Carboxylic Acid-Based Inhibitors of the SARS-CoV-2 Nsp3 Macrodomain (Mac1).
Journal: Journal of medicinal chemistry
Published: July 13, 2026
Identification of the Piperidyl Urea Derivative BAY-439 as a Potent and Selective Inhibitor of Human Phospholipase A2 Group V (hPLA2-G5) for the Treatment of Inflammatory Pain.
Journal: Journal of medicinal chemistry
Published: May 19, 2026
A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data.
Journal: Journal of chemical information and modeling
Published: February 26, 2026
How many crystal structures do you need to trust your docking results?
Journal: bioRxiv : the preprint server for biology
Published: October 03, 2025
Crystallographic Fragment Screening of the Dengue Virus Polymerase Reveals Multiple Binding Sites for the Development of Non-nucleoside Antiflavivirals.
Journal: Journal of medicinal chemistry
Published: September 02, 2025
A Structure-Based Computational Pipeline for Broad-Spectrum Antiviral Discovery.
Journal: bioRxiv : the preprint server for biology
Published: August 06, 2025
Discovery of orally bioavailable Zika and West Nile Virus antiviral compounds targeting the NS2B-NS3 protease.
Journal: bioRxiv : the preprint server for biology
Published: July 16, 2025
Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitor.
Journal: bioRxiv : the preprint server for biology
Published: July 16, 2025
Crystallographic fragment screening of the dengue virus polymerase reveals multiple binding sites for the development of non-nucleoside antiflavivirals.
Journal: bioRxiv : the preprint server for biology
Published: April 16, 2025
Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitors.
Journal: Research square
Published: February 24, 2025
Last Updated: 09/26/2026